Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

Initial findings from the Every Woman Study™: Low- and Middle-Income Countries is published in The Lancet Obstetrics, ...

Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ...

A Hudson Institute research project aiming to better understand and treat rare forms of ovarian cancer has received a big ...

Ovarian01 Phase 3 Trial of ENHERTU® Initiated as First-Line Maintenance Therapy in Patients with HER2 Expressing Advanced ...

Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology  Oslo, Norway, 8 December 2025 - Oncoinvent, a clinical stage, radiopharmaceutical ...

COIMBATORE: Under the National Health Mission (NHM), a group of surgical oncologists from eight medical college hospitals ...

Newswatch 16's Justin Gick spoke with a doctor about gynecological cancer and how early detection and access to care can save ...

Learn how fertility preservation is essential for young women diagnosed with cancer, ensuring informed choices and hope for ...

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...